Makintura, Erlinda A.
HRN: 29-46-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2026
CEFTRIAXONE 1G (VIAL)
08/11/2026
08/18/2026
IV
1g
Q12h
Acute Cholecystitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines